| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥1.84B | ¥1.85B | -0.7% |
| Cost of Sales | ¥1.29B | ¥1.20B | +7.8% |
| Gross Profit | ¥548M | ¥653M | -16.1% |
| SG&A Expenses | ¥556M | ¥573M | -2.9% |
| Operating Income | ¥-8M | ¥80M | -110.0% |
| Non-operating Income | ¥2M | ¥715,000 | +140.1% |
| Non-operating Expenses | ¥206M | ¥241M | -14.2% |
| Equity Method Investment Income | ¥-203M | ¥-238M | +14.7% |
| Ordinary Income | ¥-213M | ¥-159M | -34.0% |
| Profit Before Tax | ¥-149M | ¥-83M | -81.0% |
| Income Tax Expense | ¥7M | ¥15M | -52.3% |
| Net Income | ¥27M | ¥-101M | +126.7% |
| Net Income Attributable to Owners | ¥-145M | ¥-97M | -49.5% |
| Total Comprehensive Income | ¥-156M | ¥-97M | -60.8% |
| Depreciation & Amortization | ¥16M | ¥17M | -5.5% |
| Interest Expense | ¥3M | ¥2M | +82.6% |
| Basic EPS | ¥-20.20 | ¥-13.63 | -48.2% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥1.06B | ¥1.42B | ¥-362M |
| Cash and Deposits | ¥712M | ¥1.02B | ¥-313M |
| Accounts Receivable | ¥262M | ¥204M | +¥58M |
| Inventories | ¥11M | ¥8M | +¥2M |
| Non-current Assets | ¥421M | ¥223M | +¥198M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-12M | ¥81M | ¥-93M |
| Investing Cash Flow | ¥-252M | ¥-124M | ¥-128M |
| Financing Cash Flow | ¥-47M | ¥73M | ¥-120M |
| Free Cash Flow | ¥-264M | - | - |
| Item | Value |
|---|---|
| Operating Margin | -0.5% |
| ROA (Ordinary Income) | -13.6% |
| Book Value Per Share | ¥149.76 |
| Net Profit Margin | -7.9% |
| Gross Profit Margin | 29.8% |
| Current Ratio | 350.0% |
| Quick Ratio | 346.6% |
| Debt-to-Equity Ratio | 0.38x |
| Interest Coverage Ratio | -2.64x |
| EBITDA Margin |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -0.7% |
| Operating Income YoY Change | -36.6% |
| Ordinary Income YoY Change | -36.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 7.44M shares |
| Treasury Stock | 259K shares |
| Average Shares Outstanding | 7.19M shares |
| Book Value Per Share | ¥149.74 |
| EBITDA | ¥8M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥0.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| BusinessSolution | ¥258M | ¥-31M |
| FinancialSolutionServiceDivision | ¥1.47B | ¥394M |
| HealthCareBusinessDivision | ¥105M | ¥-51M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥2.10B |
| Operating Income Forecast | ¥100M |
| Ordinary Income Forecast | ¥10M |
| Net Income Attributable to Owners Forecast | ¥80M |
| Basic EPS Forecast | ¥11.13 |
| Dividend Per Share Forecast | ¥0.00 |
| Property, Plant & Equipment | ¥31M | ¥45M | ¥-13M |
| Intangible Assets | ¥2M | ¥3M | ¥-506,000 |
| Investment Securities | ¥261M | ¥45M | +¥216M |
| Total Assets | ¥1.48B | ¥1.65B | ¥-164M |
| Current Liabilities | ¥303M | ¥272M | +¥31M |
| Accounts Payable | ¥81M | ¥48M | +¥33M |
| Short-term Loans | ¥100M | ¥100M | ¥0 |
| Non-current Liabilities | ¥103M | ¥141M | ¥-38M |
| Long-term Loans | ¥87M | ¥127M | ¥-40M |
| Total Liabilities | ¥406M | ¥413M | ¥-7M |
| Total Equity | ¥1.08B | ¥1.23B | ¥-156M |
| Capital Stock | ¥1.48B | ¥1.48B | ¥0 |
| Capital Surplus | ¥997M | ¥997M | ¥0 |
| Retained Earnings | ¥-1.30B | ¥-1.16B | ¥-145M |
| Treasury Stock | ¥-95M | ¥-95M | ¥-23,000 |
| Owners' Equity | ¥1.08B | ¥1.22B | ¥-145M |
| Working Capital | ¥758M | - | - |
| 0.5% |
| Effective Tax Rate | -4.8% |